Skip to Content
Authors Donington JS, Blasberg JD
Author Profile(s)
Journal Thorac Surg Clin Volume: 22 Issue: 1 Pages: 55-65, vi
Publish Date 2012 Feb
PubMed ID 22108689

The preferred treatment of stage I non-small cell lung cancer (NSCLC) is anatomic resection with systematic mediastinal lymph node evaluation. However, 20% of patients with operable lung cancer are not candidates for this type of resection. Recent advancements in radiology-guided technologies have expanded the treatment options for high-risk patients with early-stage NSCLC. There has simultaneously been resurgence in interest and refinement of indications and techniques for sublobar resection in this population. While these treatments appear to have decreased peri-procedural morbidity and mortality, their oncologic efficacy compared to that of lobectomy remains to be determined. Copyright © 2017 The Board of Regents of the University of Wisconsin System